272 related articles for article (PubMed ID: 26880244)
21. EZH2 suppresses the nucleotide excision repair in nasopharyngeal carcinoma by silencing XPA gene.
Huang Y; Wang X; Niu X; Wang X; Jiang R; Xu T; Liu Y; Liang L; Ou X; Xing X; Li W; Hu C
Mol Carcinog; 2017 Feb; 56(2):447-463. PubMed ID: 27253463
[TBL] [Abstract][Full Text] [Related]
22. Cell cycle checkpoint abrogator UCN-01 inhibits DNA repair: association with attenuation of the interaction of XPA and ERCC1 nucleotide excision repair proteins.
Jiang H; Yang LY
Cancer Res; 1999 Sep; 59(18):4529-34. PubMed ID: 10493501
[TBL] [Abstract][Full Text] [Related]
23. XPA versus ERCC1 as chemosensitising agents to cisplatin and mitomycin C in prostate cancer cells: role of ERCC1 in homologous recombination repair.
Cummings M; Higginbottom K; McGurk CJ; Wong OG; Köberle B; Oliver RT; Masters JR
Biochem Pharmacol; 2006 Jul; 72(2):166-75. PubMed ID: 16756962
[TBL] [Abstract][Full Text] [Related]
24. Overexpression and purification of human XPA using a baculovirus expression system.
Hermanson IL; Turchi JJ
Protein Expr Purif; 2000 Jun; 19(1):1-11. PubMed ID: 10833384
[TBL] [Abstract][Full Text] [Related]
25. Deficient gene specific repair of cisplatin-induced lesions in Xeroderma pigmentosum and Fanconi's anemia cell lines.
Zhen W; Evans MK; Haggerty CM; Bohr VA
Carcinogenesis; 1993 May; 14(5):919-24. PubMed ID: 8504485
[TBL] [Abstract][Full Text] [Related]
26. Structural dynamics and interactions of Xeroderma pigmentosum complementation group A (XPA
Pradhan S; Mattaparthi VSK
J Biomol Struct Dyn; 2018 Oct; 36(13):3341-3353. PubMed ID: 28974143
[TBL] [Abstract][Full Text] [Related]
27. Fludarabine-mediated repair inhibition of cisplatin-induced DNA lesions in human chronic myelogenous leukemia-blast crisis K562 cells: induction of synergistic cytotoxicity independent of reversal of apoptosis resistance.
Li L; Keating MJ; Plunkett W; Yang LY
Mol Pharmacol; 1997 Nov; 52(5):798-806. PubMed ID: 9351970
[TBL] [Abstract][Full Text] [Related]
28. Expression of domains for protein-protein interaction of nucleotide excision repair proteins modifies cancer cell sensitivity to platinum derivatives and genomic stability.
Jordheim LP; Cros-Perrial E; Matera EL; Bouledrak K; Dumontet C
Clin Exp Pharmacol Physiol; 2014 Oct; 41(10):817-24. PubMed ID: 25115435
[TBL] [Abstract][Full Text] [Related]
29. Homozygous CRISPR/Cas9 Knockout Generated a Novel Functionally Active Exon 1 Skipping XPA Variant in Melanoma Cells.
Banicka V; Martens MC; Panzer R; Schrama D; Emmert S; Boeckmann L; Thiem A
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36232946
[TBL] [Abstract][Full Text] [Related]
30. DNA repair-deficient Xpa and Xpa/p53+/- knock-out mice: nature of the models.
van Steeg H; de Vries A; van Oostrom CTh ; van Benthem J; Beems RB; van Kreijl CF
Toxicol Pathol; 2001; 29 Suppl():109-16. PubMed ID: 11695546
[TBL] [Abstract][Full Text] [Related]
31. Elevation of XPA protein level in testis tumor cells without increasing resistance to cisplatin or UV radiation.
Köberle B; Roginskaya V; Zima KS; Masters JR; Wood RD
Mol Carcinog; 2008 Aug; 47(8):580-6. PubMed ID: 18240296
[TBL] [Abstract][Full Text] [Related]
32. XPA Enhances Temozolomide Resistance of Glioblastoma Cells by Promoting Nucleotide Excision Repair.
Dai W; Wu A; Li Y; Yu G; Yan X
Cell Transplant; 2022; 31():9636897221092778. PubMed ID: 35536165
[TBL] [Abstract][Full Text] [Related]
33. An investigation of the molecular basis for the synergistic interaction of tirapazamine and cisplatin.
Goldberg Z; Evans J; Birrell G; Brown JM
Int J Radiat Oncol Biol Phys; 2001 Jan; 49(1):175-82. PubMed ID: 11163512
[TBL] [Abstract][Full Text] [Related]
34. Phosphorylation of nucleotide excision repair factor xeroderma pigmentosum group A by ataxia telangiectasia mutated and Rad3-related-dependent checkpoint pathway promotes cell survival in response to UV irradiation.
Wu X; Shell SM; Yang Z; Zou Y
Cancer Res; 2006 Mar; 66(6):2997-3005. PubMed ID: 16540648
[TBL] [Abstract][Full Text] [Related]
35. PARP1 impact on DNA repair of platinum adducts: preclinical and clinical read-outs.
Olaussen KA; Adam J; Vanhecke E; Vielh P; Pirker R; Friboulet L; Popper H; Robin A; Commo F; Thomale J; Kayitalire L; Filipits M; Le Chevalier T; André F; Brambilla E; Soria JC
Lung Cancer; 2013 May; 80(2):216-22. PubMed ID: 23410825
[TBL] [Abstract][Full Text] [Related]
36. Enhanced XPA mRNA levels in cisplatin-resistant human ovarian cancer are not associated with XPA mutations or gene amplification.
States JC; Reed E
Cancer Lett; 1996 Nov; 108(2):233-7. PubMed ID: 8973600
[TBL] [Abstract][Full Text] [Related]
37. XPA gene-deficient, SCF-transgenic mice with epidermal melanin are resistant to UV-induced carcinogenesis.
Yamazaki F; Okamoto H; Miyauchi-Hashimoto H; Matsumura Y; Itoh T; Tanaka K; Kunisada T; Horio T
J Invest Dermatol; 2004 Jul; 123(1):220-8. PubMed ID: 15191564
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of the XPA repair gene increases resistance to ultraviolet radiation in human cells by selective repair of DNA damage.
Cleaver JE; Charles WC; McDowell ML; Sadinski WJ; Mitchell DL
Cancer Res; 1995 Dec; 55(24):6152-60. PubMed ID: 8521407
[TBL] [Abstract][Full Text] [Related]
39. Complementation of the DNA repair deficiency in human xeroderma pigmentosum group a and C cells by recombinant adenovirus-mediated gene transfer.
Muotri AR; Marchetto MC; Zerbini LF; Libermann TA; Ventura AM; Sarasin A; Menck CF
Hum Gene Ther; 2002 Oct; 13(15):1833-44. PubMed ID: 12396616
[TBL] [Abstract][Full Text] [Related]
40. Mouse models for xeroderma pigmentosum group A and group C show divergent cancer phenotypes.
Melis JP; Wijnhoven SW; Beems RB; Roodbergen M; van den Berg J; Moon H; Friedberg E; van der Horst GT; Hoeijmakers JH; Vijg J; van Steeg H
Cancer Res; 2008 Mar; 68(5):1347-53. PubMed ID: 18316597
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
